Lucis
Artannes-sur-indre
About Lucis
Lucis provides a health technology platform focused on biological age measurement and longevity-oriented insights using advanced diagnostics and data analysis. The company offers blood-based testing and biomarker analysis designed to assess physiological aging processes rather than chronological age. Its services translate laboratory results into structured reports that highlight metabolic health, inflammation, cellular function, and other biological indicators relevant to long-term health management. Lucis also delivers a digital interface where individuals can track changes in biological markers over time and review personalized, data-driven recommendations related to lifestyle, nutrition, and health optimization. The platform is designed for both individual users and professionals who incorporate biological age data into preventive health or wellness programs. Through its combination of diagnostics, analytics, and reporting tools, Lucis supports ongoing monitoring of health trends and informed decision-making around aging and longevity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $8.5M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: lucis.life
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Consumer Software, Health Care, Medical, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/lucis-121747 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.